Evaluation of Nomacopan for Treatment of Bullous Pemphigoid: A Phase 2a Nonrandomized Controlled Trial.

Sadik CD, Rashid H, Hammers CM, Diercks GFH, Weidinger A, Beissert S, Schauer F, Fettiplace J, Thaçi D, Ngai Y, Nunn MA, Zillikens D, Horváth B.

Open source

DOI: 10.1001/jamadermatol.2022.1156
Published: 2022-06-01
Container: JAMA Dermatol
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1001/jamadermatol.2022.1156,
  title = {Evaluation of Nomacopan for Treatment of Bullous Pemphigoid: A Phase 2a Nonrandomized Controlled Trial.},
  author = {Sadik CD and  Rashid H and  Hammers CM and  Diercks GFH and  Weidinger A and  Beissert S and  Schauer F and  Fettiplace J and  Thaçi D and  Ngai Y and  Nunn MA and  Zillikens D and  Horváth B.},
  year = {2022},
  journal = {JAMA Dermatol},
  doi = {10.1001/jamadermatol.2022.1156},
  url = {https://doi.org/10.1001/jamadermatol.2022.1156}
}

RIS

TY  - JOUR
TI  - Evaluation of Nomacopan for Treatment of Bullous Pemphigoid: A Phase 2a Nonrandomized Controlled Trial.
AU  - Sadik CD
AU  -  Rashid H
AU  -  Hammers CM
AU  -  Diercks GFH
AU  -  Weidinger A
AU  -  Beissert S
AU  -  Schauer F
AU  -  Fettiplace J
AU  -  Thaçi D
AU  -  Ngai Y
AU  -  Nunn MA
AU  -  Zillikens D
AU  -  Horváth B.
PY  - 2022
JO  - JAMA Dermatol
DO  - 10.1001/jamadermatol.2022.1156
UR  - https://doi.org/10.1001/jamadermatol.2022.1156
ER  -

APA

CD, S., H, R., CM, H., GFH, D., A, W., S, B., F, S., J, F., D, T., Y, N., MA, N., D, Z., & B., H. (2022). Evaluation of Nomacopan for Treatment of Bullous Pemphigoid: A Phase 2a Nonrandomized Controlled Trial.. JAMA Dermatol. https://doi.org/10.1001/jamadermatol.2022.1156

Source records

europe-pmc · retrieved 2026-09-26T22:54:47.322Z